IKT
#3417
Inhibikase Therapeutics, Inc. - Common Stock
2.0 6 USD
0.00%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
0.00%
Variación mensual
+23.35%
Variación en los últimos 6 meses
+24.10%
Cambio anual
+14.44%
Cierres anteriores
2.0 6
Open
2.0 7
Mínimo
2.0 5
High
2.0 9
Volumen
167
Financials
- Market Capitalization 271.99 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.82
Relación precio/flujo de caja
43.33
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3391 |  TTRX Turn Therapeutics Inc. - Common Stock | 9.60 USD | -0.41% | -14.44% | +47.24% | -4.00% | 285.97 M USD | ||
| 3403 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 19.30 USD | +1.53% | +6.51% | -16.23% | +90.52% | 283.29 M USD | ||
| 3422 |  NAGE Niagen Bioscience, Inc. - Common Stock | 3.40 USD | +3.34% | -2.02% | -3.41% | -31.73% | 270.79 M USD | ||
| 3423 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 3.66 USD | +1.67% | -2.92% | -6.15% | +30.71% | 279.86 M USD |